Agios Pharmaceuticals, Inc. (AGIO): Price and Financial Metrics
Agios Pharmaceuticals, Inc. (AGIO)
Today's Latest Price: $50.66 USD
1.09 (2.20%)
Updated Jun 5 4:00pm
Add AGIO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AGIO Stock Summary
- Of note is the ratio of Agios Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 13.23% of US stocks have a lower such ratio.
- AGIO's price/sales ratio is 19.54; that's higher than the P/S ratio of 93.17% of US stocks.
- As for revenue growth, note that AGIO's revenue has grown 50.87% over the past 12 months; that beats the revenue growth of 89.78% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Agios Pharmaceuticals Inc, a group of peers worth examining would be BPMC, RARE, DRNA, PRNB, and RGNX.
- Visit AGIO's SEC page to see the company's official filings. To visit the company's web site, go to www.agios.com.
AGIO Daily Price Range
AGIO 52-Week Price Range
AGIO Stock Price Chart More Charts
AGIO Price/Volume Stats
| Current price | $50.66 | 52-week high | $54.68 |
| Prev. close | $49.57 | 52-week low | $27.77 |
| Day low | $48.27 | Volume | 522,898 |
| Day high | $51.22 | Avg. volume | 721,090 |
| 50-day MA | $44.07 | Dividend yield | N/A |
| 200-day MA | $41.88 | Market Cap | 3.49B |
Agios Pharmaceuticals, Inc. (AGIO) Company Bio
Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...